References
- DeAngelis P. (2012). Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow. Appl Microbiol Biotechnol 94:295–305
- Debelle L, Tamburro AM. (1999). Elastin: molecular description and function. Int J Biochem Cell Biol 31:261–272
- Geisow MJ, D'Arcy Hart P, Young MR. (1981). Temporal changes of lysosome and phagosome pH during phagolysosome formation in macrophages: studies by fluorescence spectroscopy. J Cell Biol 89:645–652
- Gordon MK, Hahn RA. (2010). Collagens. Cell Tissue Res 339:247–257
- Grover A, Benet LZ. (2009). Effects of drug transporters on volume of distribution. AAPS J 11:250–261
- Hook M, Kjellen L, Johansson S. (1984). Cell-surface glycosaminoglycans. Annu Rev Biochem 53:847–869
- Necas J, Bartosikova L, Brauner P, Kolar J. (2008). Hyaluronic acid (hyaluronan): a review. Vet Med (Prague, Czech Repub.) 53:397–411
- Ohkuma S, Poole B. (1978). Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 75:3327–3331
- Shugarts S, Benet LZ. (2009). The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 26:2039–2054
- Svennebring A. (2014). Visualization of plasma and tissue binding using dose fractions parameter. Drug Dev Res 75:425–437
- Svennebring AM. (2015). The impact of the concentration of drug binding plasma proteins on drug distribution according to Oie–Tozer's model. Xenobiotica . [Epub ahead of print]. DOI: 10.3109/00498254.2015.1074764
- Tozer TN. (1984). Implications of alterer plasma protein binding in disease states. In: Benet LZ, ed. Pharmacokinetic basis for drug treatment. New York: Raven Press, 173–193